Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP654874.RAeU_izKXC-2GmPtAhRGJ7Ps2wrN9fnXHVNYWaAVEulko130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654874.RAeU_izKXC-2GmPtAhRGJ7Ps2wrN9fnXHVNYWaAVEulko130_provenance.
• NP708639.RAoXoVnAgMy2Roa35KI-Bha_5koOwHrw0OBeQiyN9Kz0s130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708639.RAoXoVnAgMy2Roa35KI-Bha_5koOwHrw0OBeQiyN9Kz0s130_provenance.
• assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP412651.RAzFxghmazHGjWLnfczZVUnEE56DtLuYd8vrQPZwwwpKk130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412651.RAzFxghmazHGjWLnfczZVUnEE56DtLuYd8vrQPZwwwpKk130_provenance.
• assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP472445.RAbYhxV4dRCHxaHhTX7a0uULsud5btPbTMiSCmOOBQlCg130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472445.RAbYhxV4dRCHxaHhTX7a0uULsud5btPbTMiSCmOOBQlCg130_provenance.
• NP394831.RAWj6P7D6-8Eq8_S7ZVs9vxFKWjYA2iF1rHbJxcHTA5_Q130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394831.RAWj6P7D6-8Eq8_S7ZVs9vxFKWjYA2iF1rHbJxcHTA5_Q130_provenance.
• assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP773402.RABQs68tHpAsufgN9itTk4irotLOg8CEr0pVCdFmrYKIA130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773402.RABQs68tHpAsufgN9itTk4irotLOg8CEr0pVCdFmrYKIA130_provenance.
• NP561584.RAqTaw-WDEhYTlhE1bV2xVxSxEXt8oQvJjYBVSDmvTGvk130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561584.RAqTaw-WDEhYTlhE1bV2xVxSxEXt8oQvJjYBVSDmvTGvk130_provenance.
• NP773400.RAQzqQrPX_T6QstpksmN4tZg_sdI0Hkcxby7TU-qMpWgw130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773400.RAQzqQrPX_T6QstpksmN4tZg_sdI0Hkcxby7TU-qMpWgw130_provenance.
• NP773406.RAeDCtbicIvpUZIOSF5fwHXChNufpE6zALDsbCYP5Xo0Q130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773406.RAeDCtbicIvpUZIOSF5fwHXChNufpE6zALDsbCYP5Xo0Q130_provenance.
• NP773407.RAQLxzWQ1SW-svCc1zRM4dJQlGgKQ7ukHoGAOR_CeeY7M130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773407.RAQLxzWQ1SW-svCc1zRM4dJQlGgKQ7ukHoGAOR_CeeY7M130_provenance.
• assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP967186.RAkektI0Mz-5bRZFrrW6vp9RSxiahNV-D-0XotAY_JxGI130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967186.RAkektI0Mz-5bRZFrrW6vp9RSxiahNV-D-0XotAY_JxGI130_provenance.
• NP967188.RAoZkNCPjKxR8_xvtqVo7kwjtv1-HMbNI0yqKmuEapjhw130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967188.RAoZkNCPjKxR8_xvtqVo7kwjtv1-HMbNI0yqKmuEapjhw130_provenance.
• NP942385.RAlP3Vb86jQoCi8CGCDMGVlUqXitX8EiILPuaLkJh5LEs130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP942385.RAlP3Vb86jQoCi8CGCDMGVlUqXitX8EiILPuaLkJh5LEs130_provenance.
• NP942388.RAnsdEobdNd3cBFT98IqCnQce9Mc5NCzqdTggmVw69CB4130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP942388.RAnsdEobdNd3cBFT98IqCnQce9Mc5NCzqdTggmVw69CB4130_provenance.
• NP914054.RAKBAk4lAInZbzCiR-zBjeyxs4G7Mv4VVOrocvfjr1c4I130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914054.RAKBAk4lAInZbzCiR-zBjeyxs4G7Mv4VVOrocvfjr1c4I130_provenance.
• NP773395.RAuJv9zGQ4a4tEghANdxZY8BucgIAEIfylj2F64JN80uY130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773395.RAuJv9zGQ4a4tEghANdxZY8BucgIAEIfylj2F64JN80uY130_provenance.
• NP773398.RAsTlXFjWQqaDEW5F7vdYY7CymF5PRySL6VEtKB9xuGtY130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773398.RAsTlXFjWQqaDEW5F7vdYY7CymF5PRySL6VEtKB9xuGtY130_provenance.
• NP773401.RAk6WomBjQOjtqbMozFUQK0OeltWPEHcc95OAZn5EQgSY130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773401.RAk6WomBjQOjtqbMozFUQK0OeltWPEHcc95OAZn5EQgSY130_provenance.
• NP773404.RAm21zlMXY_iErylUb5cDnaBtqZQVXZBV39XWAHvzVz5s130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773404.RAm21zlMXY_iErylUb5cDnaBtqZQVXZBV39XWAHvzVz5s130_provenance.
• NP394851.RA4KeWJhI2GBjBbqsyoA0C_e6vl3NRMkxU0WMgdOGyKdI130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394851.RA4KeWJhI2GBjBbqsyoA0C_e6vl3NRMkxU0WMgdOGyKdI130_provenance.
• NP562039.RA_mJOx5L4yghNLHCBIotTvDNq9zfrRh73Zmkubp_QT0Q130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562039.RA_mJOx5L4yghNLHCBIotTvDNq9zfrRh73Zmkubp_QT0Q130_provenance.
• NP561744.RAHAXEmYF9_S6whuu8nw6bkg2RKUmtPbv0Q6CFFZn6dgE130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561744.RAHAXEmYF9_S6whuu8nw6bkg2RKUmtPbv0Q6CFFZn6dgE130_provenance.
• NP352390.RA-1S5wdgVQ9Bs4GulfAqsus_wXXcZBKYrpE-uz55T29w130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352390.RA-1S5wdgVQ9Bs4GulfAqsus_wXXcZBKYrpE-uz55T29w130_provenance.
• NP352407.RA9YIDVkL0nekOIlNPwzNsfTzGsyZXcoJgpU7Bt4L0vvg130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352407.RA9YIDVkL0nekOIlNPwzNsfTzGsyZXcoJgpU7Bt4L0vvg130_provenance.
• NP472322.RAMwCFy6ztyHDyXrqVczWgDuCqE4WmruLZi9c25fVT7VU130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472322.RAMwCFy6ztyHDyXrqVczWgDuCqE4WmruLZi9c25fVT7VU130_provenance.
• NP352374.RAKtcg0_kw7XEGaNOwXFRiGVcdLPuxm97Q-WY5s_Nr7yY130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352374.RAKtcg0_kw7XEGaNOwXFRiGVcdLPuxm97Q-WY5s_Nr7yY130_provenance.
• NP967187.RAI0N8RSmIlgSVXmZh-lYPZirY2iwpcT3LXvJ8LhiEAXQ130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967187.RAI0N8RSmIlgSVXmZh-lYPZirY2iwpcT3LXvJ8LhiEAXQ130_provenance.
• NP773409.RALJcDe4dWY729LWZf9XYMpTXKmAgAg6EANbS9rUR2Q7I130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773409.RALJcDe4dWY729LWZf9XYMpTXKmAgAg6EANbS9rUR2Q7I130_provenance.
• NP773396.RA7mgD2TnKmXbcvj4B2FePABWUysbH9PWFms1AF7xTDRU130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773396.RA7mgD2TnKmXbcvj4B2FePABWUysbH9PWFms1AF7xTDRU130_provenance.
• NP773397.RA-r0iFHCN73TpSSwz2B2_9mY60RQVCehkAWE3GSz7q-Q130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773397.RA-r0iFHCN73TpSSwz2B2_9mY60RQVCehkAWE3GSz7q-Q130_provenance.
• NP773399.RA1mW1MkPgbJFsbXDHSXThHH5hFLjRZdFFETPrddDsKbE130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773399.RA1mW1MkPgbJFsbXDHSXThHH5hFLjRZdFFETPrddDsKbE130_provenance.
• NP773403.RA7hJH8YQ_qbRhzmhZ1BFiSPGHDwWi5MbCzOdkhFznyqc130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773403.RA7hJH8YQ_qbRhzmhZ1BFiSPGHDwWi5MbCzOdkhFznyqc130_provenance.
• NP773405.RA8ahD40MJQvFyDy5_SWgO7qrLkBy-L5EQTdufmY3HnAQ130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773405.RA8ahD40MJQvFyDy5_SWgO7qrLkBy-L5EQTdufmY3HnAQ130_provenance.
• NP773408.RA_NIe6aB1QH_rDbRbIXrRMUTbzLKPt9uFJ7XHRS7NjOI130_assertion description "[In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773408.RA_NIe6aB1QH_rDbRbIXrRMUTbzLKPt9uFJ7XHRS7NjOI130_provenance.